LEADER 04360nam 2200577 450 001 9910795443803321 005 20230814235331.0 010 $a1-61537-170-2 035 $a(CKB)4340000000245890 035 $a(MiAaPQ)EBC5294185 035 $a(OCoLC)1103280047 035 $a(Au-PeEL)EBL5294185 035 $a(CaPaEBR)ebr11512268 035 $a(OCoLC)1024284552 035 $a(EXLCZ)994340000000245890 100 $a20180310h20182018 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aOffice-based buprenorphine treatment of opioid use disorder /$fedited by John A. Renner Jr., M.D., Petros Levounis, M.A., Anna T. LaRose, M.D 205 $aSecond edition. 210 1$aArlington, Virginia :$cAmerican Psychiatric Association Publishing,$d2018. 210 4$dİ2018 215 $a1 online resource (xix, 375 pages) $cillustrations 225 1 $aProQuest Ebook Central 311 1 $a1-61537-083-8 320 $aIncludes bibliographical references and index. 327 $aOpioid use disorder in america : history and overview / John A. Renner Jr -- General opioid pharmacology / John T. Pichot, Mark T. Pichot -- Efficacy and safety of buprenorphine / Eric C. Strain, Gerard Iru I. Fernando -- Patient assessment / Petros Levounis, Jonathan Avery -- Clinical use of buprenorphine / Ricardo Restrepo, Petros Levounis -- Buprenorphine treatment in office-based settings / Jeffrey D. Baxter, Dong Chan Park -- Psychosocial and supportive treatment / Peter D. Friedmann, Tae Woo Park -- Referral, logistics, and diversion / Joji Suzuki, Claudia P. Rodriguez -- Methadone, naltrexone, and naloxone / Brad W. Stankiewicz, Saria El Haddad, Anna Terajewicz Larose -- Psychiatric comorbidity / Elie Aoun, Elinore F. McCance-Katz -- Medical comorbidity / Joseph H. Donroe, Lynn E. Fiellin, David A. Fiellin, Jeanette M. Tetrault -- Acute and chronic pain / Daniel P. Alford -- Opioid use by adolescents / Ximena Sanchez-Samper, Sharon Levy -- Women's health and pregnancy / Anna T. LaRose, Hendree E. Jones -- Comments on the case vignettes / John A. Renner Jr., Gregory Acampora. 330 $aWith a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)?an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women?s health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher 410 0$aProQuest Ebook Central. 606 $aOpioid abuse$xChemotherapy 606 $aBuprenorphine$xTherapeutic use 606 $aOpioid-Related Disorders$xdrug therapy 606 $aBuprenorphine$xtherapeutic use 615 0$aOpioid abuse$xChemotherapy. 615 0$aBuprenorphine$xTherapeutic use. 615 2$aOpioid-Related Disorders$xdrug therapy. 615 22$aBuprenorphine$xtherapeutic use. 676 $a615/.7822 702 $aRenner$b John A.$cJr.,$f1938- 702 $aLevounis$b Petros 702 $aLaRose$b Anna T.$f1979- 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910795443803321 996 $aOffice-based buprenorphine treatment of opioid use disorder$93795913 997 $aUNINA